p-Index From 2021 - 2026
0.562
P-Index
This Author published in this journals
All Journal Narra J
Muhammad Yani
Department of Public Health, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Association and predictive performance of platelet-to-lymphocyte ratio and maternal serum ferritin level for preterm birth: A prospective cohort study Sofie D. Wahyudi; Cut M. Yeni; Niken A. Utami; Hasanuddin Hasanuddin; Yusra Septivera; Muhammad Yani
Narra J Vol. 6 No. 2 (2026): August 2026
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v6i2.3131

Abstract

Although maternal inflammation is increasingly recognized in the pathogenesis of preterm birth, evidence regarding the combined predictive value of platelet-to-lymphocyte ratio (PLR) and maternal serum ferritin levels remains scarce. The aim of this study was to evaluate the association and predictive performance of PLR and maternal serum ferritin levels, two readily available inflammatory biomarkers, with the incidence of preterm birth. A prospective cohort study was conducted. Pregnant women with singleton pregnancies between 28 and 36 weeks 6 days of gestation were consecutively recruited and followed until delivery. PLR was calculated from absolute platelet and lymphocyte counts obtained from complete blood count analysis, while maternal serum ferritin levels were measured using electrochemiluminescence immunoassay. The present study found that higher PLR (odds ratio (OR): 1.013; 95%CI: 1.002–1.025; p=0.025) and maternal serum ferritin levels (OR: 1.016; 95%CI: 1.002–1.031; p=0.029) were significantly associated with the incidence of preterm birth. In multivariable analysis, PLR ≥134.4 (adjusted OR: 3.701; 95%CI: 1.186–11.548; p=0.024) and maternal serum ferritin levels ≥29.3 ng/mL (adjusted OR: 4.513; 95%CI: 1.351–15.075; p=0.014) remained independently associated with preterm birth. Receiver operating characteristic analysis demonstrated very modest discriminatory performance for both PLR (area under the curve (AUC): 0.632, p=0.076) and maternal serum ferritin levels (AUC: 0.645, p=0.052), with optimal cut-off values of 134.4 and 29.3 ng/mL, respectively. These findings support the contribution of maternal inflammatory processes to the development of preterm birth and suggest that PLR and maternal serum ferritin levels may provide complementary information for risk assessment. However, the modest predictive performance observed indicates that these biomarkers are unlikely to be sufficient as standalone screening tools and should be interpreted alongside established clinical predictors.
Diagnostic performance of hematological inflammatory biomarkers for assessing endometriosis severity and pelvic pain severity Mala Hayati; Rusnaidi Rusnaidi; Ima Indirayani; Hasanuddin Hasanuddin; Dewi K. Rusly; Muhammad Yani
Narra J Vol. 6 No. 3 (2026): December 2026 (In Press)
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v6i3.3130

Abstract

Endometriosis is a chronic inflammatory disease frequently associated with pelvic pain and infertility. Since systemic inflammation may reflect disease activity, hematological inflammatory biomarkers obtained from routine blood tests have been proposed as non-invasive indicators of endometriosis severity. The aim of this study was to evaluate the association of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and monocyte-to-lymphocyte ratio (MLR) with endometriosis severity and pelvic pain severity, as well as to assess their diagnostic performance. A cross-sectional study was conducted at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia, among women with histopathologically confirmed endometriosis. Endometriosis severity was classified intraoperatively according to the revised American Society for Reproductive Medicine (rASRM) staging system. Pelvic pain severity was assessed preoperatively using the Numeric Rating Scale (NRS). Hematological inflammatory biomarkers were calculated from preoperative complete blood count results. The associations and diagnostic performance of the biomarkers in relation to endometriosis severity and pelvic pain severity were evaluated using correlation analysis and receiver operating characteristic (ROC) curve analysis. Our data indicated that NLR (r=0.460; p<0.001), SII (r=0.439; p=0.001), and MLR (r=0.391; p=0.003) had significant positive correlations with endometriosis severity, whereas PLR demonstrated a borderline correlation (r=0.261; p=0.050). ROC analysis showed good diagnostic performance for NLR (AUC=0.784; p=0.005), SII (AUC=0.777; p=0.006), and MLR (AUC=0.783; p=0.005), while PLR was not statistically significant (AUC=0.679; p=0.078). NLR (r=0.295; p=0.026) and SII (r=0.275; p=0.038) showed weak but significant positive correlations with pelvic pain severity, whereas PLR and MLR had no significant association. None of the biomarkers demonstrated significant diagnostic performance for pelvic pain severity. NLR, SII, and MLR may serve as accessible and inexpensive adjunctive indicators of endometriosis severity, particularly in resource-limited settings; however, their utility for assessing pelvic pain severity appears limited.
Association and discriminative performance of TNF-α and CA125 for disease severity and pain severity in endometriosis patients Rauzatul Jannah; Rusnaidi Rusnaidi; Hasanuddin Hasanuddin; Cut Meurah Yeni; Dewi Karlina Rusly; Muhammad Yani
Narra J Vol. 6 No. 3 (2026): December 2026 (In Press)
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v6i3.3132

Abstract

Endometriosis is a chronic inflammatory disease frequently associated with pelvic pain and disease progression. Tumor necrosis factor-alpha (TNF-α) and cancer antigen 125 (CA125) have been proposed as potential biomarkers reflecting inflammatory activity and disease burden. However, evidence remains limited on whether these biomarkers are associated with both anatomical disease severity and pain severity, particularly among patients with histopathologically confirmed endometriosis. The aim of this study was to evaluate the associations and discriminative performance of TNF-α and CA125 in relation to endometriosis severity and pain severity. A cross-sectional study was conducted at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia, from October 2025 to January 2026, in which women with histopathologically confirmed endometriosis were included. Disease severity was classified intraoperatively using the revised American Society for Reproductive Medicine (rASRM) system. Pain severity was assessed using the Numeric Rating Scale (NRS). Peritoneal fluid TNF-α was measured using enzyme-linked immunosorbent assay (ELISA), and serum CA125 was measured using electrochemiluminescence immunoassay (ECLIA). Associations were analyzed using Spearman correlation, and discriminative ability was assessed using receiver operating characteristic (ROC) curve analysis. CA125 showed a significant positive correlation with rASRM stage (r=0.401; p=0.005) and TNF-α showed no significant correlation (r=0.068; p=0.649). ROC analysis demonstrated that CA125 had good discriminative ability for disease severity (AUC=0.808; p<0.001) with an optimal cut-off value of 32 U/mL. For pain severity, both CA125 (r=0.344; p=0.018) and TNF-α (r=0.338; p=0.020) had weak but significant positive correlations with NRS scores. ROC analysis indicated fair discriminative ability of CA125 (AUC=0.700; p=0.010) and TNF-α (AUC=0.674; p=0.031) for severe pain, with optimal cut-off values of 50.85 U/mL and 0.023 pg/mL, respectively. These findings highlight that CA125 is more consistently associated with endometriosis severity than TNF-α, while both biomarkers show limited ability to discriminate pain severity.